Nordic Pharma
Paris, 75007, France
NCT Number: NCT02529501
The purpose of this study is to describe, in real-life conditions, the factors influencing the choice of anesthesia (spinal anesthesia or short general anesthesia) in outpatient surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75007, France
This is a cross-sectional, observational, prospective, multicentre study, conduct in France among a representative sample of anesthesiologists.
The factors influencing the choice of anesthesia (spinal anesthesia or short general anesthesia) will be assessed in patients undergoing an outpatient surgery. Data will be collected by the physician during the inclusion visit (peripostoperative consultation). Additional data regarding the patient's perception (pain and satisfaction) will be collected using a self-questionnaire 7 days after the surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: During the perioperative consultation (patients are included at the time of the perioperative consultation prior to their surgery): baseline visit
All proposed factors will be described using a 4-levels verbal scale (decisive / important / of little importance / unimportant). The factors will be described from the questionnaire completed by the investigator during the inclusion visit, before the surgery.
Decisive factors for the choice of anesthesia will be described and compared between the two subgroups.spinal anesthesia and short general anesthesia.
Time frame: At the time of the perioperative consultation prior to their surgery (start of the inclusion visit or baseline visit)
Patients' characteristics (demographic data, ASA physical status, risk factors...) will be described from the questionnaire completed by the investigator during the inclusion visit, before the surgery.
Time frame: Up to 24h after the surgery
Will be described from the questionnaire completed by the investigator during the inclusion visit, after the surgery.
Time frame: 7 days after surgery (i.e. 7 days after the inclusion)
Will be described from the self-questionnaire completed by the patient 7 days after the surgery.
Time frame: Up to 7 days after surgery
Will be described from the self-questionnaire completed by the patient 7 days after the surgery.
Time frame: The day of the surgery
Will be described from the questionnaire completed by the investigator during the inclusion visit.
Time frame: During surgery
Modalities of spinal anesthesia with prilocaine. Percentage and nature of adverse effect (serious or not) after intrathecal anaesthesia with prilocaine.
Nordic Pharma SAS
Industry
Factors Influencing the Choice of Anesthesia (Spinal Anesthesia or Short General Anesthesia) in Outpatient Surgery
Acronym: BAG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02152293
Outpatient Surgery, Spinal Anesthesia
Paris, France
View Trial DetailsNCT07718360
Cesarean Section Pain, Neurologic Manifestations
Islamabad, Federal Capital Territory, Pakistan
View Trial DetailsNCT06711601
Intercristal Line, Posterior Superior Iliac Spine
Guangzhou, Guangdong, China
View Trial DetailsNCT07676955
Cesarean Birth, Sedation
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial Details